PuSH - Publikationsserver des Helmholtz Zentrums München

162 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
121.
Schnopp, C.* ; Grosch, J.* ; Ring, J. ; Ollert, M.* & Mempel, M.: Microbial allergen-specific IgE is not suitable to identify the intrinsic form of atopic eczema in children. J. Allergy Clin. Immunol. 121, 267-268 (2008)
122.
von Berg, A.* et al.: Preventive effect of hydrolyzed infant formulas persists until age 6 years: Long-term results from the German Infant Nutritional Intervention Study (GINI). J. Allergy Clin. Immunol. 121, 1442-1447 (2008)
123.
Weidinger, S. et al.: Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J. Allergy Clin. Immunol. 121, 1203-1209 (2008)
124.
Weidinger, S. et al.: Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J. Allergy Clin. Immunol. 122, 560-568 (2008)
125.
Wjst, M.: Allergy risk of vitamin D supplements has been described in various settings. J. Allergy Clin. Immunol. 121, 1065-1066 (2008)
126.
Baurecht, H. et al.: Toward a major risk factor for atopic eczema: Meta-analysis of filaggrin polymorphism data. J. Allergy Clin. Immunol. 120, 1406-1412 (2007)
127.
Belloni, B.* et al.: Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels. J. Allergy Clin. Immunol. 120, 1223-1225 (2007)
128.
Chen, C.M. et al.: Longitudinal study on cat allergen exposure and the development of allergy in young children. J. Allergy Clin. Immunol. 119, 1148-1155 (2007)
129.
Gutermuth, J. et al.: Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo. J. Allergy Clin. Immunol. 120, 293-299 (2007)
130.
Hartl, D.* et al.: Quantitative and functional impairment of pulmonary CD4⁺CD25hi regulatory T cells in pediatric asthma. J. Allergy Clin. Immunol. 119, 1258-1266 (2007)
131.
Huss-Marp, J. et al.: Exhaled nitric oxide in children with asthma at high altitude - Reply J. Allergy Clin. Immunol. 120, 1227-1228 (2007)
132.
Huss-Marp, J. et al.: Reduced exhaled nitric oxide values in children with asthma after inpatient rehabilitation at high altitude. J. Allergy Clin. Immunol. 120, 470-471 (2007)
133.
Jarvis, D.* et al.: Cat and dust mite allergen levels, specific IgG and IgG4, and respiratory symptoms in adults. J. Allergy Clin. Immunol. 119, 697-704 (2007)
134.
Kerzl, R.* ; Simonowa, A.* ; Ring, J.* ; Ollert, M. & Mempel, M.: Life-threatening anaphylaxis to kiwi fruit: Protective sublingual allergen immunotherapy effect persists even after discontinuation. J. Allergy Clin. Immunol. 119, 507-508 (2007)
135.
Lim, A. et al.: The IgE repertoire in PBMCs of atopic patients is characterized by individual rearrangements without variable region of the heavy immunoglobulin chain bias. J. Allergy Clin. Immunol. 120, 696-706 (2007)
136.
Real, F.G.* et al.: Menstrual irregularity and asthma and lung function. J. Allergy Clin. Immunol. 120, 557-564 (2007)
137.
von Berg, A.* et al.: Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: Three-year results of the German Infant Nutritional Intervention Study. J. Allergy Clin. Immunol. 119, 718-725 (2007)
138.
Alessandrini, F. et al.: Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung. J. Allergy Clin. Immunol. 117, 824-830 (2006)
139.
Hartl, D.* et al.: Pulmonary Th2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117, 204-211 (2006)
140.
Heinrich, J. et al.: Cat allergen level: Its determinants and relationship to specific IgE to cat across European centers. J. Allergy Clin. Immunol. 118, 674-681 (2006)